sr 33557 has been researched along with Coronary Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castaigne, A; Dubois-Randé, JL; Habbal, R; Lellouche, D; Saal, JP; Sissmann, J | 1 |
1 other study(ies) available for sr 33557 and Coronary Disease
| Article | Year |
|---|---|
Hemodynamic effects of a new calcium antagonist, SR 33557, in patients with coronary artery disease and normal left ventricular function.
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Cardiac Catheterization; Coronary Disease; Heart Rate; Hemodynamics; Humans; Indolizines; Injections, Intravenous; Male; Middle Aged; Phenethylamines; Vascular Resistance; Ventricular Function, Left | 1994 |